BMY vs PAYO · P/E 17, rev $24.46B vs P/E 24, rev $535.9M
Bristol-Myers Squibb Company (BMY) versus Payoneer Global Inc (PAYO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Payoneer Global Inc (PAYO) is a software - infrastructure company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported PAYO revenue for 2026-06-30 was $535.9M. Net income was $17.1M. PAYO currently screens at market cap $2.40B and trailing P/E 23.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. PAYO currently screens at market cap $2.40B and trailing P/E 23.7.
Not investment advice. Open the BMY and PAYO stock pages for the full models.
Not investment advice.